| Patent | Date |
|---|
PDE III inhibitors for treatment of asymptomatic heart failure
Grant 11,413,285 - Daemmgen , et al. August 16, 2 | 2022-08-16 |
Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
Grant 10,537,588 - Daemmgen , et al. Ja | 2020-01-21 |
Pde Iii Inhibitors For Treatment Of Asymptomatic Heart Failure
App 20190008862 - Daemmgen; Juergen ; et al. | 2019-01-10 |
PDE III inhibitors for treatment of asymptomatic heart failure
Grant 10,117,869 - Daemmgen , et al. November 6, 2 | 2018-11-06 |
Use Of Pde Iii Inhibitors For The Reduction Of Heart Size In Mammals Suffering From Heart Disease
App 20180185402 - DAEMMGEN; Juergen ; et al. | 2018-07-05 |
Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
Grant 9,889,148 - Daemmgen , et al. February 13, 2 | 2018-02-13 |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
Grant 9,463,199 - Daemmgen , et al. October 11, 2 | 2016-10-11 |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
Grant 9,375,469 - Vaughn , et al. June 28, 2 | 2016-06-28 |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
Grant 8,980,894 - Daemmgen , et al. March 17, 2 | 2015-03-17 |
Use of vaccines for the treatment/prevention of the transmission of pathogens
Grant 8,883,123 - Daemmgen , et al. November 11, 2 | 2014-11-11 |
Use Of Pde Iii Inhibitors For The Reduction Of Heart Size In Mammals Suffering From Heart Failure
App 20140155338 - DAEMMGEN; Juergen ; et al. | 2014-06-05 |
Phosphodiesterase type III (PDE III) inhibitors or CA.sup.2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
Grant 8,664,252 - Daemmgen , et al. March 4, 2 | 2014-03-04 |
Novel H5 Proteins, Nucleic Acid Molecules And Vectors Encoding For Those, And Their Medicinal Use
App 20140050755 - VAUGHN; Eric Martin ; et al. | 2014-02-20 |
Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure
App 20130317008 - GUTH; Brian ; et al. | 2013-11-28 |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
Grant 8,592,558 - Vaughn , et al. November 26, 2 | 2013-11-26 |
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
Grant 8,524,701 - Guth , et al. September 3, 2 | 2013-09-03 |
Pde Iii Inhibitors For Treatment Of Asymptomatic Heart Failure
App 20130203690 - Daemmgen; Juergen ; et al. | 2013-08-08 |
Novel H5 Proteins, Nucleic Acid Molecules And Vectors Encoding For Those, And Their Medicinal Use
App 20120231027 - VAUGHN; Eric ; et al. | 2012-09-13 |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
Grant 8,202,967 - Vaughn , et al. June 19, 2 | 2012-06-19 |
Phosphodiesterase Type Iii (pde Iii) Inhibitors Or Ca2+-sensitizing Agents For The Treatment Of Hypertrophic Cardiomyopathy
App 20110251208 - Daemmgen; Juergen ; et al. | 2011-10-13 |
Use of PDE III Inhibitors For The Treatment of Asymptomatic (Occult) Heart Failure
App 20100035889 - Daemmgen; Juergen ; et al. | 2010-02-11 |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
App 20090082282 - Daemmgen; Juergen ; et al. | 2009-03-26 |
Use Of A Specific Cyclic Amine Derivative Or The Pharmaceutically Acceptable Salts Thereof For The Treatment Or Prevention Of Heart Failure
App 20080312210 - GUTH; Brian ; et al. | 2008-12-18 |
Vaccination Of Horses Against Lawsonia Intracellularis
App 20080241190 - Kroll; Jeremy ; et al. | 2008-10-02 |
Novel H5 Proteins, Nucleic Acid Molecules And Vectors Encoding For Those, And Their Medicinal Use
App 20080193471 - Vaughn; Eric ; et al. | 2008-08-14 |
Use Of Vaccines For The Treatment/prevention Of The Transmission Of Pathogens
App 20070207168 - Daemmgen; Juergen ; et al. | 2007-09-06 |
Use Of Bradycardiac Substances In The Treatment Of Myocardial Diseases Associated With Hypertrophy And Novel Medicament Combinations
App 20070155679 - Daemmgen; Juergen ; et al. | 2007-07-05 |
Use Of A Specific Cyclic Amine Derivative Or The Pharmaceutically Acceptable Salts Thereof For The Treatment Or Prevention Of Heart Failure
App 20070142354 - Guth; Brian ; et al. | 2007-06-21 |
Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
Grant 7,208,508 - Daemmgen , et al. April 24, 2 | 2007-04-24 |
Method For Improving Diagnostic Quality In Echocardiography
App 20070054838 - Stark; Marcus ; et al. | 2007-03-08 |
Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor
App 20060217431 - Daemmgen; Juergen ; et al. | 2006-09-28 |
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
App 20060063840 - Guth; Brian ; et al. | 2006-03-23 |
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
App 20040138306 - Guth, Brian ; et al. | 2004-07-15 |
Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
App 20040014795 - Daemmgen, Juergen ; et al. | 2004-01-22 |
| 